
Dr. Mark Yarchoan of Johns Hopkins Sidney Kimmel Comprehensive Cancer Center has been awarded the Blue Faery Award for Excellence in Liver Cancer Research, recognizing his significant contributions to understanding and treating hepatocellular carcinoma (HCC).
As an Associate Professor of Medical Oncology, Yarchoan leads an NCI-funded laboratory dedicated to overcoming barriers in antitumor immunity. His groundbreaking research focuses on innovative immunotherapy treatments for liver cancers, including conducting the first clinical trials of a personalized neoantigen vaccine for HCC and neoadjuvant anti-PD1 immunotherapy.
Primary liver cancer remains the third leading cause of cancer-related deaths worldwide, making research like Yarchoan’s critically important. His work extends beyond laboratory research, as he actively participates in international guideline committees for liver cancers through the American Association for the Study of Liver Diseases and the American Society of Clinical Oncology.
Blue Faery: The Adrienne Wilson Liver Cancer Association established this annual award to support and recognize medical professionals advancing liver cancer research. The organization, founded by Andrea Wilson Woods in memory of her sister Adrienne, who passed away from HCC at 15, is committed to preventing, treating, and curing primary liver cancer through research, education, and advocacy.
Yarchoan expressed gratitude for the recognition, emphasizing the collaborative nature of medical research. ‘I am deeply honored to receive the Blue Faery Award, which not only supports liver cancer research but also highlights the strength of the community driving progress in this field,’ he stated.
The award, funded by AstraZeneca this year, underscores the critical need for continued research and innovation in liver cancer treatment. Blue Faery’s ongoing efforts include providing comprehensive patient education through resource guides and awareness programs such as Love Your Liver and The Truth About Liver Cancer.

This news story relied on a press release distributed by 24-7 Press Release. Blockchain Registration, Verification & Enhancement provided by NewsRampâ„¢. The source URL for this press release is Johns Hopkins Oncologist Honored for Liver Cancer Research Breakthrough.